by Deborah Abrams Kaplan | Aug 5, 2024 | Issue 3: Q3 2024
Navigating the Complex Landscape of Biopharma Employment After a decade at Pfizer, immunologist Mary Sutton was laid off in February. Sutton (not her real name) has been looking for another mid-level executive position in new drug development since getting the WARN...
by Sarah Ellinwood | Aug 5, 2024 | Issue 3: Q3 2024
It’s not just the application process that attracts bad actors as highlighted in previous article, “The Recruiter & The Thief” not everyone who applies is interested in the role, some are interested in stealing IP or strategic insights. Employment...
by Natalie Zimmerman | Aug 5, 2024 | Issue 3: Q3 2024
Job interviews can be intensely nerve-wracking experiences. With a potential job offer on the line and nerves running high, it can be difficult for candidates to toe the line between professional and memorable… and occasionally, a candidate takes their desire to be...
by Eric Celidonio | Aug 5, 2024 | Issue 3: Q3 2024
Glassdoor’s Decline: Why Going Back to Basics is (and has always been) Key for Genuine Company Insights Glassdoor was once the go-to for semi-authentic company reviews, but since its acquisition by Recruit Holdings Co., Ltd., it seems the site is being...